Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leishmania donovani | 11 | 2024 | 24 | 3.670 |
Why?
|
| Leishmaniasis, Visceral | 10 | 2024 | 20 | 3.280 |
Why?
|
| Macrophages | 15 | 2025 | 688 | 1.810 |
Why?
|
| Leishmania | 7 | 2025 | 35 | 1.670 |
Why?
|
| Leishmaniasis | 6 | 2025 | 40 | 1.590 |
Why?
|
| Leishmaniasis, Cutaneous | 6 | 2024 | 49 | 1.580 |
Why?
|
| CD40 Antigens | 3 | 2024 | 27 | 1.200 |
Why?
|
| Host-Parasite Interactions | 4 | 2024 | 81 | 1.090 |
Why?
|
| Leishmania major | 6 | 2025 | 27 | 1.050 |
Why?
|
| Mice, Inbred BALB C | 14 | 2024 | 1045 | 0.990 |
Why?
|
| Drug Resistance | 2 | 2024 | 252 | 0.840 |
Why?
|
| CD40 Ligand | 1 | 2023 | 64 | 0.810 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2024 | 200 | 0.800 |
Why?
|
| Cytokines | 8 | 2025 | 1359 | 0.800 |
Why?
|
| Protozoan Proteins | 4 | 2025 | 133 | 0.710 |
Why?
|
| Toll-Like Receptor 2 | 5 | 2024 | 55 | 0.680 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 271 | 0.670 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 198 | 0.620 |
Why?
|
| Phosphorylcholine | 3 | 2024 | 28 | 0.600 |
Why?
|
| Parasites | 3 | 2023 | 36 | 0.560 |
Why?
|
| Leishmaniasis Vaccines | 3 | 2023 | 20 | 0.530 |
Why?
|
| Signal Transduction | 9 | 2025 | 4703 | 0.500 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 1743 | 0.440 |
Why?
|
| Protein Isoforms | 3 | 2023 | 422 | 0.390 |
Why?
|
| Animals | 23 | 2025 | 34785 | 0.390 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 2 | 2023 | 5 | 0.380 |
Why?
|
| Mice | 16 | 2025 | 18461 | 0.350 |
Why?
|
| Interferon-gamma | 4 | 2024 | 534 | 0.300 |
Why?
|
| ras Proteins | 2 | 2023 | 146 | 0.230 |
Why?
|
| Toll-Like Receptors | 2 | 2023 | 84 | 0.220 |
Why?
|
| Receptors, Immunologic | 1 | 2025 | 126 | 0.220 |
Why?
|
| Virulence Factors | 1 | 2025 | 187 | 0.210 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2023 | 25 | 0.210 |
Why?
|
| Interleukin-7 | 1 | 2023 | 48 | 0.210 |
Why?
|
| Immunity | 2 | 2023 | 183 | 0.210 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2023 | 207 | 0.200 |
Why?
|
| Antiprotozoal Agents | 1 | 2022 | 41 | 0.190 |
Why?
|
| Spleen | 2 | 2023 | 270 | 0.180 |
Why?
|
| Ligands | 4 | 2024 | 494 | 0.170 |
Why?
|
| Protein Kinase C | 1 | 2021 | 119 | 0.170 |
Why?
|
| Antimony | 1 | 2020 | 14 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 4752 | 0.170 |
Why?
|
| Humans | 17 | 2025 | 131934 | 0.170 |
Why?
|
| Amphotericin B | 1 | 2020 | 91 | 0.160 |
Why?
|
| Macrophages, Peritoneal | 1 | 2020 | 39 | 0.160 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2020 | 31 | 0.160 |
Why?
|
| Immunotherapy | 1 | 2025 | 744 | 0.160 |
Why?
|
| Vaccines, DNA | 1 | 2020 | 48 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 101 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 493 | 0.160 |
Why?
|
| Mammals | 3 | 2024 | 272 | 0.140 |
Why?
|
| Mitochondrial Proteins | 1 | 2020 | 260 | 0.140 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 163 | 0.140 |
Why?
|
| Skin | 1 | 2020 | 527 | 0.140 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 540 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 445 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2025 | 1576 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1960 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2022 | 916 | 0.120 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 2 | 2024 | 20 | 0.110 |
Why?
|
| Ion Channels | 2 | 2024 | 207 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2020 | 1610 | 0.090 |
Why?
|
| Th1 Cells | 2 | 2023 | 156 | 0.090 |
Why?
|
| Inflammation | 1 | 2018 | 1519 | 0.080 |
Why?
|
| RNA, Small Interfering | 2 | 2024 | 687 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2024 | 1608 | 0.070 |
Why?
|
| Interleukin-10 | 2 | 2020 | 187 | 0.070 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2023 | 10 | 0.050 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2023 | 12 | 0.050 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2023 | 24 | 0.050 |
Why?
|
| Glycosphingolipids | 1 | 2023 | 11 | 0.050 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2023 | 22 | 0.050 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2023 | 21 | 0.050 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2023 | 22 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2023 | 117 | 0.050 |
Why?
|
| Peptidoglycan | 1 | 2023 | 22 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2023 | 234 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2023 | 142 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 140 | 0.050 |
Why?
|
| Receptors, Interferon | 1 | 2022 | 22 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 309 | 0.050 |
Why?
|
| Pathogen-Associated Molecular Pattern Molecules | 1 | 2021 | 6 | 0.040 |
Why?
|
| Receptor Cross-Talk | 1 | 2021 | 36 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2023 | 677 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 131 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2021 | 78 | 0.040 |
Why?
|
| B7-H1 Antigen | 1 | 2022 | 125 | 0.040 |
Why?
|
| Dogs | 1 | 2022 | 652 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 500 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 441 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 488 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2021 | 238 | 0.040 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2020 | 6 | 0.040 |
Why?
|
| Disease Resistance | 1 | 2020 | 27 | 0.040 |
Why?
|
| Lipogenesis | 1 | 2020 | 60 | 0.040 |
Why?
|
| Vaccines, Attenuated | 1 | 2020 | 176 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2020 | 145 | 0.040 |
Why?
|
| Antibodies, Protozoan | 1 | 2020 | 94 | 0.040 |
Why?
|
| Virulence | 1 | 2020 | 279 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2020 | 116 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 239 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2020 | 601 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 356 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 294 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3678 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2020 | 876 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 806 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2018 | 327 | 0.030 |
Why?
|
| Lipids | 1 | 2020 | 561 | 0.030 |
Why?
|
| Monocytes | 1 | 2018 | 340 | 0.030 |
Why?
|
| Liver | 1 | 2023 | 1796 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2018 | 471 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 3037 | 0.030 |
Why?
|
| Transcriptome | 1 | 2020 | 1122 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2020 | 1580 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 4682 | 0.020 |
Why?
|
| Female | 2 | 2024 | 70592 | 0.010 |
Why?
|
| Male | 1 | 2025 | 64877 | 0.010 |
Why?
|